淫羊藿对肌肉素质的影响的临床与实验研究
摘要
目的
观察淫羊藿对人及大鼠肌系统的影响
方法
1选择50例肾阳虚型骨质疏松症患者,将50例患者随机分为治疗组、对照组两组,疗程为6个月。治疗组服用单味淫羊藿煎液,共28例;对照组服用福善美(阿仑膦酸钠片Alendronate Sodium Tablets每片含阿仑膦酸钠70mg,由默沙东公司提供),共22例。观察治疗前及治疗后6个月检查骨密度、肾阳虚积分及利手肌力变化.
2 SD大鼠,雌性,260～300g,52只,随机分为假手术组16组,模型组12只,阳性组12只,淫羊藿组12只。模型组、阳性组及淫羊藿组行卵巢切除手术;假手术组动物进行开背,但不切除卵巢。手术后7天开始给药,1次/天,连续给药12周,每周测量动物的体重、饮食量各一次。观察的肌肉蛋白含量、超氧化物歧化酶(SOD)活力、谷胱甘肽过氧化物酶(GSH-PX)、丙二醛(MDA)、肌纤维直径、横截面积及周长。
结果
1通过对50例绝经后骨质疏松症患者的分组对照治疗发现,治疗组经单味淫羊藿煎剂口服治疗后,其症状总有效率(包括显效、有效)为91.67%,与对照组福善美口服后总有效率68.42%相比,两组有显著性差异(P＜0.01)。治疗组治疗前后比较,肾阳虚主要症状腰膝酸软、畏寒肢冷积分值与肾阳虚证总积分值差异均有非常显着性意义(P＜0.01);对照组治疗前后比较,肾阳虚主要症状积分值及肾阳虚总积分值均无明显变化。2组之间治疗后肾阳虚主要症状积分值及肾阳虚证总积分比较差异均有显著性意义。治疗组骨密度值疗前、疗后比较有显著性差异(P＜0.05);对照组骨密度值疗前、疗后比较有显著性差异(P＜0.05)。治疗组与对照组疗后骨密度值比较无显著性差异(P＞0.05)。治疗组与对照组在治疗前与治疗后2个月、4个月及6个月均存在显著差异(P＜0.05),而治疗后2个月、4个月及6个月间的握力比较无显著差异。治疗组与对照组比较,治疗前握力无差异,治疗后各测试阶段治疗组均较对照组高,差异具有显著性(P＜0.05)。
2大鼠切除卵巢后,相对于未切除卵巢的大鼠,骨骼肌在组织形态学上发生了改变,主要表现在骨骼肌纤维直径、横截面积、周长上的缩小,同时在单位面积上骨骼肌的数量是增大的,阳性组的大鼠,骨骼肌中的蛋白含量较模型组的大鼠有明显的提高(P＜0.05),抗氧化酶SOD的活力也明显高于去卵巢手术后的大鼠(P＜0.01),GSH-PX的活力更是为各组的最高值,达到105.122活力单位,明显超过卵巢摘除大鼠(P＜0.01),肌肉中的脂质过氧化物MDA含量显著低于模型组(P＜0.01)。为卵巢切除后大鼠的骨骼肌的蛋白质含量为0.600 g/L,SOD的活力为36.353U/mgprot,GSH-PX的活性为70.181活力单位,MDA的含量为28.503mg/prot,高于其它各组。淫羊藿治疗对股直肌各项检测指标的影响显示如下:肌肉蛋白含量和SOD活力是各实验组中最高的,比去卵巢组分别提高了21.50%和82.35%(P＜0.01),而且SOD活力还与其它组之间存在显著性差异(P＜0.05)。GSH-PX的活性高于去卵巢组(P＞0.05),但明显低于阳性组(P＜0.05)。淫羊藿治疗后大鼠肌肉中MDA含量低于其它实验组,比去卵巢组减少了51.06%(P＜0.01)。
结论
1表明淫羊藿在缓解临床症状及改善患者症状方面较福善美有显著的优势;淫羊藿具有提高骨密度,促进骨形成的、改善患者肌力的作用,而且优于福善美。
2淫羊藿能够增强骨质疏松大鼠肌肉抗氧化能力、提高自由基清除率、延缓机体衰老、改善骨骼肌的质量和功能。营养或能够使骨质疏松大鼠模型的肌纤维横截面积增大、直径增大,改善了骨骼肌退变,提高了骨骼肌素质。
Objective:
To observe the influence of epimedium on muscle system of human and rat
Methods:
1 We randomly divide 50 osteoporosis patients who were insufficiency of kidney-YANG types into treatment groups and control groups and these patients received treatment for 6 months.The treatment groups were 28 and received single epimedium fluid.And control groups were 22 and treated with Fosamax(Alendronate Sodium Tablets70mg).Bone density,index of insufficiency of kidney-YANG type and muscle force of hand were determined pro and post 6 months of treatment.
2 52 SD rats(female,260-300g) were randomly divided into pseud-operation groups(16),model groups(12),positive groups(12),epimedium groups(12). ovariectomy was performed in model,positive and epimedium groups.The rats in pseudo-operation group were cut on the back and ovariectomy was not performed. Medicine(once a day) were given in 7 day after operation up to 12 weeks,the heavy and appetite of rats were measured once a week.Protein level in muscle,SOD activity, GSH-PX,MDA,diameter,cross section area and perimeter of muscle were measured.
Results:
1 From analysis the treatment of 50 postmenopause osteoporsis patients,we found that the total effective rate were 91.67%in treatment groups and 68.42%in control which is significantly difference(P＜0.01).E2 index in pro and post treatment were significantly difference in treatment groups(P＜0.01) and no difference were found in control group(P＞0.05).the major syndrome index and total syndrome index of insufficiency of kidney-YANG types showed no difference in control groups but showed significantly difference in two groups.Bone density of pro and post treatment showed significantly difference in treatment and control groups(P＜0.05).It is not difference found in bone density in treatment and control groups(P＞0.05).it is significantly difference between pro treatment and 2,4,6 months after treatment in treatment and control groups(P＜0.05) and no difference were found in grasp force between pro treatment and 2,4,6 months after treatment.ALP and BGP showed no difference in pro and post treatment(P＞0.05).grasp force in treatment groups were significantly higher than in control in all time points.(P＜0.05).
2 After ovariectomy,some histomorphologies were found in muscle including diminution diameter,cross section and peridiameter of muscle fibre and increasion of muscle pre area.protein level and SOD activity of muscle in positive groups increased significantly compared to model groups(P＜0.05,P＜0.01).GSH-PX activity was 105.122 unit which was highest in all groups and higher than ovariectomy rats(P＜0.01).MDA content in muscle was significantly lower than model groups(P＜0.01).
Protein level in muscle of ovariectomy rats were 0.600g/L,SOD activity was 36.353U/mgprot,GSH-PX activity was 70.181 unit,MDA content was 28.503mg/prot which higher than other groups.The influence of epimedium on rectus femoris were shown follow as:protein level and SOD activity were highest in all groups which elevated to21.05%and 82.35%respectively(P＜0.01),moreover,the SOD activity was significantly higher than other groups(P＜0.05).GSH-PX activity were higher than ovariectomy groups(P＞0.05),but significantly lower than positive groups(P＜0.05).after epimedium treatment,MDA content in rat muscle decreased by 51.06%than ovariectomy groups and lower than other groups(P＜0.01).
Conclusions:
1 We found that epimedium have obviously superiority on relief clinical syndrome and cure patients syndrome than Fosamax.Epimedium could increase bone density and bone formation and strength muscle force and better than Fosamax.
2 Epimedium could promote muscle ability of antioxygen,increase free radical deletion,delay muscle aging,improve quality and function of muscle of rats. moreover,Epimedium could enlarge diameter,cross section area of muscle fibre, inhibit muscle cataplasid and promote muscle quality.
观察淫羊藿对人及大鼠肌系统的影响
方法
1选择50例肾阳虚型骨质疏松症患者,将50例患者随机分为治疗组、对照组两组,疗程为6个月。治疗组服用单味淫羊藿煎液,共28例;对照组服用福善美(阿仑膦酸钠片Alendronate Sodium Tablets每片含阿仑膦酸钠70mg,由默沙东公司提供),共22例。观察治疗前及治疗后6个月检查骨密度、肾阳虚积分及利手肌力变化.
2 SD大鼠,雌性,260～300g,52只,随机分为假手术组16组,模型组12只,阳性组12只,淫羊藿组12只。模型组、阳性组及淫羊藿组行卵巢切除手术;假手术组动物进行开背,但不切除卵巢。手术后7天开始给药,1次/天,连续给药12周,每周测量动物的体重、饮食量各一次。观察的肌肉蛋白含量、超氧化物歧化酶(SOD)活力、谷胱甘肽过氧化物酶(GSH-PX)、丙二醛(MDA)、肌纤维直径、横截面积及周长。
结果
1通过对50例绝经后骨质疏松症患者的分组对照治疗发现,治疗组经单味淫羊藿煎剂口服治疗后,其症状总有效率(包括显效、有效)为91.67%,与对照组福善美口服后总有效率68.42%相比,两组有显著性差异(P＜0.01)。治疗组治疗前后比较,肾阳虚主要症状腰膝酸软、畏寒肢冷积分值与肾阳虚证总积分值差异均有非常显着性意义(P＜0.01);对照组治疗前后比较,肾阳虚主要症状积分值及肾阳虚总积分值均无明显变化。2组之间治疗后肾阳虚主要症状积分值及肾阳虚证总积分比较差异均有显著性意义。治疗组骨密度值疗前、疗后比较有显著性差异(P＜0.05);对照组骨密度值疗前、疗后比较有显著性差异(P＜0.05)。治疗组与对照组疗后骨密度值比较无显著性差异(P＞0.05)。治疗组与对照组在治疗前与治疗后2个月、4个月及6个月均存在显著差异(P＜0.05),而治疗后2个月、4个月及6个月间的握力比较无显著差异。治疗组与对照组比较,治疗前握力无差异,治疗后各测试阶段治疗组均较对照组高,差异具有显著性(P＜0.05)。
2大鼠切除卵巢后,相对于未切除卵巢的大鼠,骨骼肌在组织形态学上发生了改变,主要表现在骨骼肌纤维直径、横截面积、周长上的缩小,同时在单位面积上骨骼肌的数量是增大的,阳性组的大鼠,骨骼肌中的蛋白含量较模型组的大鼠有明显的提高(P＜0.05),抗氧化酶SOD的活力也明显高于去卵巢手术后的大鼠(P＜0.01),GSH-PX的活力更是为各组的最高值,达到105.122活力单位,明显超过卵巢摘除大鼠(P＜0.01),肌肉中的脂质过氧化物MDA含量显著低于模型组(P＜0.01)。为卵巢切除后大鼠的骨骼肌的蛋白质含量为0.600 g/L,SOD的活力为36.353U/mgprot,GSH-PX的活性为70.181活力单位,MDA的含量为28.503mg/prot,高于其它各组。淫羊藿治疗对股直肌各项检测指标的影响显示如下:肌肉蛋白含量和SOD活力是各实验组中最高的,比去卵巢组分别提高了21.50%和82.35%(P＜0.01),而且SOD活力还与其它组之间存在显著性差异(P＜0.05)。GSH-PX的活性高于去卵巢组(P＞0.05),但明显低于阳性组(P＜0.05)。淫羊藿治疗后大鼠肌肉中MDA含量低于其它实验组,比去卵巢组减少了51.06%(P＜0.01)。
结论
1表明淫羊藿在缓解临床症状及改善患者症状方面较福善美有显著的优势;淫羊藿具有提高骨密度,促进骨形成的、改善患者肌力的作用,而且优于福善美。
2淫羊藿能够增强骨质疏松大鼠肌肉抗氧化能力、提高自由基清除率、延缓机体衰老、改善骨骼肌的质量和功能。营养或能够使骨质疏松大鼠模型的肌纤维横截面积增大、直径增大,改善了骨骼肌退变,提高了骨骼肌素质。
Objective:
To observe the influence of epimedium on muscle system of human and rat
Methods:
1 We randomly divide 50 osteoporosis patients who were insufficiency of kidney-YANG types into treatment groups and control groups and these patients received treatment for 6 months.The treatment groups were 28 and received single epimedium fluid.And control groups were 22 and treated with Fosamax(Alendronate Sodium Tablets70mg).Bone density,index of insufficiency of kidney-YANG type and muscle force of hand were determined pro and post 6 months of treatment.
2 52 SD rats(female,260-300g) were randomly divided into pseud-operation groups(16),model groups(12),positive groups(12),epimedium groups(12). ovariectomy was performed in model,positive and epimedium groups.The rats in pseudo-operation group were cut on the back and ovariectomy was not performed. Medicine(once a day) were given in 7 day after operation up to 12 weeks,the heavy and appetite of rats were measured once a week.Protein level in muscle,SOD activity, GSH-PX,MDA,diameter,cross section area and perimeter of muscle were measured.
Results:
1 From analysis the treatment of 50 postmenopause osteoporsis patients,we found that the total effective rate were 91.67%in treatment groups and 68.42%in control which is significantly difference(P＜0.01).E2 index in pro and post treatment were significantly difference in treatment groups(P＜0.01) and no difference were found in control group(P＞0.05).the major syndrome index and total syndrome index of insufficiency of kidney-YANG types showed no difference in control groups but showed significantly difference in two groups.Bone density of pro and post treatment showed significantly difference in treatment and control groups(P＜0.05).It is not difference found in bone density in treatment and control groups(P＞0.05).it is significantly difference between pro treatment and 2,4,6 months after treatment in treatment and control groups(P＜0.05) and no difference were found in grasp force between pro treatment and 2,4,6 months after treatment.ALP and BGP showed no difference in pro and post treatment(P＞0.05).grasp force in treatment groups were significantly higher than in control in all time points.(P＜0.05).
2 After ovariectomy,some histomorphologies were found in muscle including diminution diameter,cross section and peridiameter of muscle fibre and increasion of muscle pre area.protein level and SOD activity of muscle in positive groups increased significantly compared to model groups(P＜0.05,P＜0.01).GSH-PX activity was 105.122 unit which was highest in all groups and higher than ovariectomy rats(P＜0.01).MDA content in muscle was significantly lower than model groups(P＜0.01).
Protein level in muscle of ovariectomy rats were 0.600g/L,SOD activity was 36.353U/mgprot,GSH-PX activity was 70.181 unit,MDA content was 28.503mg/prot which higher than other groups.The influence of epimedium on rectus femoris were shown follow as:protein level and SOD activity were highest in all groups which elevated to21.05%and 82.35%respectively(P＜0.01),moreover,the SOD activity was significantly higher than other groups(P＜0.05).GSH-PX activity were higher than ovariectomy groups(P＞0.05),but significantly lower than positive groups(P＜0.05).after epimedium treatment,MDA content in rat muscle decreased by 51.06%than ovariectomy groups and lower than other groups(P＜0.01).
Conclusions:
1 We found that epimedium have obviously superiority on relief clinical syndrome and cure patients syndrome than Fosamax.Epimedium could increase bone density and bone formation and strength muscle force and better than Fosamax.
2 Epimedium could promote muscle ability of antioxygen,increase free radical deletion,delay muscle aging,improve quality and function of muscle of rats. moreover,Epimedium could enlarge diameter,cross section area of muscle fibre, inhibit muscle cataplasid and promote muscle quality.
引文
[1]陈大蓉,唐显著,郑坤渝等。中药护骨合剂防治绝经后骨质疏松症的临床研究。中医杂志,1994,35(6):359
[2]丁桂芝,张忠兰,周勇等。补肾健骨胶囊治疗绝经后骨质疏松症疗效分析。中国中西医结合杂志,1995,15(7):392。
[3]谢雁鸣,张方直,周文泉等。补肾生髓胶囊治疗肾阳虚证原发性骨质疏松症的临床研究,中国中西医结合杂志,1997,17(9):526。
[4]史炜镔,王济伟,符诗聪等。骨松Ⅰ号治疗绝经后骨质疏松症初步临床观察,中国骨伤,1996,9(6):3
[5]王和鸣,葛继荣,李楠。补骨合剂治疗老年性骨质疏松的临床观察,中国中医骨伤科杂志,1998,6(4):13
[6]李洪成,郭素华,林如平等。补肾药虎潜丸对肾虚患者骨密度的影响,中国中西医结合杂志,1997,17(11):669。
[7]周丕琪,沈霖,杨艳萍等。密骨片治疗绝经后骨质疏松症的临床研究,中国中医骨伤杂志1995,5(1):20-22
[8]蒋淑媛,尚亚平,吴林生等。骨疏康颗粒治疗骨质疏松症的临床观察(附300例分析),中国骨质疏松杂志,1995,1(2):167。,1997,5(1):20。
[9]赵永芳,张戈,史万忠等。骨质疏松症中医证型的初步临床报告,中医正骨,141998,10(5):9。
[10]邵敏,庄洪,宋文昭。绝经后骨质疏松症生存质量和中医证型的初步研究,中医正骨,2000,12(5):9。
[11]谢可永.补肾法治疗骨质疏松症55例疗效观察,上海中医药杂志,1986,27 (11)
[12]梁立.补肾中药治疗骨质疏松症的临床观察。中医杂志,1992,33(11):39。
[13]张贵有。老年性骨质疏松症中医证治探讨,浙江中医学院学报,1996,20(1):8。
[14]齐振熙。辩证治疗绝经后骨质疏松症,中国中医骨伤科杂志,1998,6(3):28。
[15]黄勇。老年性脊椎骨质疏松并压缩骨折的诊治-附53例报告,中医正骨,1993,4(3):13。
[16]许书亮,张永重。骨质疏松症的辩证分型与治疗,中国中医骨伤科杂志,3(4):30。
[17]丛春雨。女性绝经后骨质疏松症的中医中药治疗,中国骨质疏松杂志,1999,5(4):7。
[18]史炜镔,杜宁,符诗聪等。中药对去势兔骨代谢影响的骨计量学研究,中国中医骨伤科杂志,1996,4(4):8。
[19]丁桂芝,周勇,李榕等。补肾健骨胶囊防治维甲酸造成的大鼠骨质疏松症的研究,同济医科大学学报,1995,24(4):285。
[20]吴波,徐冰,黄添友等。抗骨松剂对维甲酸所致骨质疏松症的防治作用,中国中西医结合杂志,1996,16(1):32。
[21]刘和娣,李恩,佟晓旭等。补肾方药对地塞米松诱发的骨质疏松大鼠体内雌激素和1,25羟维生素D3的影响,中国中西医结合杂志,1993,13(9):544。
[22]谢晶,杜靖远,沈霖。补肾密骨液作用于卵巢切除大鼠的骨组织计量学研究,中国中医骨伤科杂志,1995,3(6):1。
[23]冯坤,刘月桂,张灵菊等。中药坚骨液对卵巢切除后骨质疏松大鼠血、尿生化的影响,中医正骨,1996,8(1):3。
[24]陶有略,方亮,叶大付等。黔岭藿合剂对大鼠卵巢切除诱发实验性骨质疏 松症的影响,中国中医骨伤科杂志,4(6):10。
[25]沈霖,杜靖远,杨家玉等。密骨片防治去睾大鼠骨质疏松症的研究,中国中医骨伤科杂志,1997,5(1):4。
[26]姚共和,谢林,郭振球。金刚健骨片对绝经后骨质疏松症骨形成与骨吸收失衡的双向调节作用,中国中医骨伤科杂志,1999,7(2):6。
[27]杜靖远,沈霖,杨家玉等。补肾密骨液对大鼠卵巢切除诱导的实验性骨质疏松症的影响,中华骨科杂志,1996,16(7):462。
[28]李青南,疗进民,吴铁等。淫羊藿预防羟基尿致雄性大鼠骨质疏松的定量研究,中国中医骨伤科杂志,1996,4(3):1。
[29]孙苏亚,王锦,刘铮等。龟板提取液对去势大鼠骨质疏松的作用,中药药理与临床,1998,4(4):20。
[30]季晖,刘康,李绍平等。淫羊藿总黄酮对维A酸诱导大鼠骨质疏松症的防治作用,中国药科大学学报,2000,3(3):222。
[31]马中书,王蕊,邱明才等。四种补肾中药对去卵巢大鼠骨质疏松骨形态的作用,中华妇产科杂志,1999,34(2):82。
[32]于世风,陈坤,章魁华等。中药对骨吸收作用的实验研究,现代口腔医学杂志,1999,13(1):1。
[33]李朝阳,吴铁,黄连芳等。黄芪水提液与已烯雌酚对去卵巢大鼠骨代谢的影响,中草药,1998,29(1):27。
[34]沈霖,杜靖远,赵海波。补肾法对IL-1诱导的破骨细胞性骨吸收及破骨细胞MMP-9的影响,中医正骨,1999,11(7):3。
[35]沈霖,杜靖远,赵海波。补肾法对实验性骨质疏松MMP-9及Ⅰ型胶原mRNA 表达的影响,中国中医骨伤科杂志,1998,6(4):1。
[36]唐海涛,唐海,罗先正等。骨疏康对成骨细胞刺激作用的研究,中国骨质疏松杂志,2000,6(2):60。
[37]沈霖,杜靖远,胡光亮等。密骨片对离体胎鼠颅骨成骨细胞增殖及及幼鼠 颅骨块钙释放的影响,中医研究,2000,13(1):22。
[38]李芳芳,李恩,宋士军等。补肾方剂及不同分离组份对成骨细胞增殖分化的影响,中国骨质疏松杂志,1998,4(3):71。
[39]杜靖远,胡光亮。夏志道等。补肾密骨液对体外培养新生大鼠颅骨成骨细胞增殖的影响,中华实验外科杂志,1998,15(5):465。
[40]郭昭庆,党耕町,王志国。氟化钠及续断组份对成骨细胞增殖的影响,中华骨科杂志,1998,18(2):84。
[41]黄岚,冯树芳,王洪复等。雷公藤内酯醇对体外培养的成骨细胞增殖的影响,中华皮肤科杂志,2000,33(2):96。
[42]黄岚,冯树芳,魏道材等。雷公藤多甙体外对成骨细胞功能表达的影响,中华风湿病学杂志,2000,4(2):
[43]黄岚,冯树芳,王洪复等。雷公藤多甙对体外成骨细胞增殖的影响,上海医科大学学报,2000,27(1):51。
[44]李学武,李晓泓,张露芬等。天灸防治去卵巢大鼠骨质疏松的实验研究,中国骨质疏松杂志,1998,4(3):58。
[45]刘献祥,吴炳煌,吴明霞等。针灸对原发性骨质疏松症影响的实验研究,福建中医学院学报,2000,10(1):21。
[46]赵英侠,严振国,余安胜。针灸对卵巢切除大鼠骨代谢的影响,上海针灸杂志,1999,18(5):40。
[47]孙晓明,罗南萍,杨道理等。珍牡胶囊与霜叶红联用对老年男性骨质疏松患者骨代谢指标的影响,放射免疫学杂志,2000,13(2):75。
[48]崔少千,王海义,李书琴等。骨疏康冲剂与钙剂联合应用防治维甲酸所致大鼠骨质疏松的实验研究,中国骨质疏松杂志,1999,5(2):74。
[49]尹文哲,王伟,敖英芳。阿法D3与补肾健骨胶囊联合使用对大鼠实验性骨质疏松的影响,中国运动医学杂志,1999,18(1):282。
[50]张乃钲,韩旭华。中西医结合治疗绝经后骨质疏松症的研究,中国中医骨 伤科杂志,1995,3(1):14。
[51]Xiaobo Wanga,Genevi'eve A.Dumasa.Evaluation of effects of selected factors on intervertebral fusion a simulation study.Medical Engineering &Physics,2005,27:197-207.
[52]White Ⅲ AA,Panjabi MM.Clinical Biomechanics of the Spine.Philadelphia:J.B.Lippincott,1990.
[53]Hukins DWL.Disc structure and function.In:Ghosh P,ed.The Biology of the Intervertebral Disk I.Boca Raton,Florida;CRC Press,1988:1-37.
[54]Smit TH,Odgaard A,Schneider E.Structure and function of vertebral trabecular bone.Spine.1997 Dec 15;22(24):2823-33.
[55]李健,徐晖,程立明等.胸腰段椎体压缩性骨折三维有限元模型的建立及其意义.中国临床解剖学杂志.2005,23(2):199-201.
[56]Xiaobo Wanga,Genevi'eve A.Dumasa.Evaluation of effects of selected factors on intervertebral fusion a simulation study.Medical Engineering &Physics,2005,27:197-207.
[57]赵燕玲,潘子昂,王石麟。中国原发性骨质疏松症流行病学,中国骨质疏松杂志,1998,4(1):1.
[58]张平,李健,张美超,等.胸腰段三维有限元模型的建立.2005,33(4):7-10.
[59]程立明,陈仲强,张美超等.胸腰段后凸畸形对相邻椎间盘力学影响的三维有限元分析.中国临床解剖学杂志,2003,21(3):273-276.
[60]吴浩波,严世贵,陈其昕等.不同运动负荷下腰椎应力的三维非线性有限元分析.中国运动医学杂志,2004,23(5):480-484.
[61]陈新民,郎继孝,陈德喜等.应用三维有限元模型研究颈的生物力学变化.临床骨科杂志.2003,6(4):294-296.
[62]中国老年学会骨质疏松委员会骨质疏松诊断标准学科组.中国人骨质疏松症建议诊断标准(第二版)[J].中国骨质疏松杂志,2000;6(1):1-3
[63]包丽华,林华,李建华,等.二瞵酸盐治疗对骨质疏松性骨痛、骨密度、骨强度的疗效及安全性评价[J].中华老年医学杂志,2003;22(11):659-662.
[64]秦岭,张戈,译.美国国家卫生院有关骨质疏松症的预防、诊断和治疗的共识文件[J].中国骨质疏松杂志,2002;8(1):90-93.
[65]郝永强,戴克戎.骨质疏松性骨折愈合的细胞超微结构观察.中华骨科杂志,2004,24(11):670-673.
[66]Melton Ⅲ LJ,Chrischilles EA,etal.Perspective How many women have osteoporosis.J Bone Miner Res.1992;7:1005-10.
[67]EPOS-group.Incidence of vertebral fracture in Europe:results from the European Prospective Osteoporosis Study(EPOS).J Bone Miner Res 2002;17:716-24.
[68]J.A.Kanis,O.Johnell A.Oden F.Borgstrom N.Zethraeus C.De Laet B.JonssonThe risk and burden of vertebral fractures in Sweden.Osteoporos Int (2004)15:20-26.
[69]Mosekilde L.Consequences of the remodelling process for vertebral trabecular bone structure:a scanning electron microscopy study(uncoupling of unloaded structures).Bone Miner 1990;10:13-35.
[70]J.Homminga,B.Van-Rietbergen,E.M.Lochmu,et al.The osteoporotic vertebral structure is well adapted to the loads of dally life,but not to infrequent‘error'loads.Bone,2004,34:510-516.
[71]Fechtenbaum J,Cropet C,Kolta S,et al.The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women.Osteoporos Int.2005,16(12):2175-9.
[72]Cummings SR,Kelsey JL,Nevitt MC,et al..Epidemiology of osteoporosis and osteoporotic fracture[J].Epide mid Rev,1985,7:178-208.
[73]Speocer H,Kraner L.NIH consensus conference:Osteoporosis,factors contributing to osteoporosis[J].J Nutr,1986,116:319-322.
[74]Peck WA.The nature and epidemiology of osteoporosis.In:Peck WA,eds.Trends and Perspectives in the Diagnosis and Management of Osteoporosis.New Jersey:The Parthenon Publishing Group,1989;11-19.
[75]Gueguen Y,Bard M.The understanding and recognition of osteoporosis.Switzerland,1989;34.
[76]J.A.Kanis,O.Johnell A.etal.The risk and burden of vertebral fractures in Sweden.Osteoporos Int,2004,15:20-26.
[77]郭庆升,孙国强,张世斌,等.应用双能X线骨密度仪对辽宁地区正常人群骨密度的流行病学调查[J]中国骨质疏松杂志,2002,8(2),107-9.
[78]安珍,王文志,杨定焯,等.成都地区城乡人群原发性骨质疏松调查[J].中国骨质疏松杂志,2002,8(3):233-6.
[79]林伟,邓力平,邬恒夫,等.广州地区1530例骨密度分析及骨质疏松发病率研究[J]中国骨质疏松杂志,2003,9(3),257-9.
[80]徐栋梁,李佛保,陈维清,等,广州地区老年人群骨质疏松性骨折和骨关节病的流行病学调查和分析[J]中国骨质疏松杂志,2000,6(3),73-6.
[81]区品中,邓力平,刘毅生,等.广州地区中老年人群骨量减少及骨质疏松患病率的调查[J]中国骨质疏松杂志,2003,8(4)314-8.
[82]陈健,陈治卿,余玲玲,等.厦门岛中老年人骨质疏松症发病率调查[J].四川医学,2001,22(8),785-787.
[83]Mosekide L,Bentzen SM,The predictive value of quantitative computed tomography for vertebral body compressive strength and ash desity.Bone,1989,10:465.
[84]Goldstein SA,Goulet R.McCubbrey D,Measurement and significance of three-dimensional architecture in mechanical integrity of trabecular bone.Calcif Tissue Int,1993,53:S127.
[85]Johnell O,Kanis JA,etal.Predictive value of BMD for hip and other fractures.J Bone Miner Res.2005,20(7):1185-94.
[86]Sornay-Rendu E,Munoz F,Garnero P,et al.Identification of osteopenic women at high risk of fracture:the OFELY study.J Bone Miner Res.2005,20(10):1813-9.
[87]Chevalley T,Hoffmeyer P,Bonjour JP,Rizzoli R.An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture.Osteoporos Int;2002,13:450-455.
[88]Mulherin D,Williams S,Smith JA,et al.Identification of risk factors for future fracture in patients following distal forearm fracture.Osteoporos Int.2003Sep;14(9):757-60.
[89]郭世绂 骨质疏松性椎体骨折 中国矫形外科杂志2005年11月第13卷第22期1685-1687.
[90]Cuddihy MT,Gabriel SE,Crowson CS,O'Fallon WM,Melton LJ.Forearm fractures as predictors of subsequent osteoporotic fractures.Osteoporos Int.1999,9:469-475.
[91]Cummings SR.Case-finding for prevention of fractures.Osteoporosis ensitometry,diagnosis,treatment,prevention,rehabilitation and patient education,2000:73-75.
[92]Seeman E.Clinial approach to patients with osteoporosis.Osteoporosis ensitometry,diagnosis,treatment,prevention,rehabilitation and patient education,2000:17-25.
[93]Kanis JA,Johnell O,etal.A meta-analysis of previous fracture and subsequent fracture risk.Bone.2004,35(2):375-82.
[94]Barthe N,Basse-Cathalinat B,Meunier PJ,et al.Measurement of bone mineral density in monther-daughter pairs for evaluating the family influence on bone mass acquisition:a GRIO survey.Osteoporos Int,1998,8:379-384.
[95]De Laet C,Kanis JA,et al.Body mass index as a predictor of fracture risk:a meta-analysis.Osteoporos Int.2005,16(11):1330-8.
[96]Sornay-Rendu E,Munoz F,et al.Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women:the OFELY study.J Bone Miner Res.2005,20(11):1929-35.
[97]Mikko Haara,Markku Heli(o|¨)vaara3,Olli Impivaara3,et al.Low metacarpal index predicts hip fracture:A prospective population study of 3,561 subjects with 15 years of follow-up.Acta Orthopaedica 2006,77(1):9-14.
[98]Sornay-Rendu E,Munoz F,etal.Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women:the OFELY Study.J Bone Miner Res.2004,19(12):1994-1999.
[99]Ross PD,Davis JW,Epstein RS,Wasnich RD.Pre-existing fractures and bone mass predict vertebral fracture incidence in women.Ann Intern Med.1991,114(11):919-23.
[100]Black DM,Arden NK,Palermo L,et al.Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures.Study of Osteoporotic Fractures Research Group.J Bone Miner Res.1999,14(5):821-8.
[101]Garnero P,Delmas PD.Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.J Musculoskelet Neuronal Interact.2004,4(1):50-63.
[102]张彤,李万根.绝经后妇女血清瘦素水平与骨代谢的关系.中国骨质疏松杂志,2005,11(3):317-318.
[103]Kanis JA,Johansson H,etal.Alcohol intake as a risk factor for fracture.Osteoporos Int.2005,16(7):737-42.
[104]Albrand G,Munoz F,et al.Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women:the OFELY study.Bone.2003,32(1):78-85.;Kanis JA,Borgstrom F,etal.Assessment of fracture risk.Osteoporos Int.2005,16(6):581-9.
[105]Maldague BE,Noel HM,Malgheim JJ.The intra vertebral vacuum cleft:a sign of ischemic vertebral collapse.Radiology 1978;129:23-9.
[106]Hashimoto K,Yasui N,Yamagishi M,Kojimoto H,Mizuno K,Shimomura Y.Intra vertebral vacuum cleft in the fifth vertebra.Spinel989;14:351-4.
[107]Baba H,Maezawa Y,Kamitani K,et al.Osteoporotic vertebral collapse with late neurological complications.Paraplegia 1995;33:281-9.;Brower AC,Downey EF.Kummell disease:report of a case with serial radiographs.Radiology 1981;141:363-4.
[108]Cho LM,Knight RQ.Idiopathic avascular necrosis of a vertebral body.Case report and literature review.Spine 1997;22:1928-32.
[109]Hasegawa K,Homma T,Uchiyama S,Takahashi H.Vertebral pseudarthrosis in the osteoporotic spine.Spine 1998;23:2201-6.
[110]Kaplan PA,Orton DF,Aselson RJ.Osteoporosis with vertebral compression fractures,retropulsed fragments,and neurologic compromise.Radiology 1987;165:533-5.
[111]刘忠厚.骨质疏松学[M].科学出版社,1998:142.
[112]沈光宇,杨卫新.康复医学[M].南京:东南大学出版社,2002:104-105.
[113]谭文捷,周宏图.脉冲电磁场并紫外线照射治疗骨质疏松症234例.中国临床康复.2003,15:2223.
[114]谭文捷,周宏图.绝经后骨质疏松症综合康复治疗86例.江苏大学学报(医 学版).2003,13(4):342-343.
[115]翁瑛霞 高巧英 邵宏伟等.126例骨质疏松患者的疼痛与脉冲电磁场疗效的初步分析.中国骨质疏松杂志,2003,9(4):317-319.
[116]高家纯,高巧英.脉冲电磁场改善骨质疏松症患者关节疼痛及痉挛症状849例观察.中国临床康复.2004,8(6):1720-1721.
[117]罗文娟,张小红,陈敏.中药离子导入治疗骨质疏松症疼痛效果观察及护理.护理学杂志,2004,19(8):65-66.
[118]黎小坚,Harold M Frost,朱绍舜,等.基础骨生物学新观[J].中国骨质疏松杂志,2001;7(3):253-261.
[119]肖建德.实用骨质疏松学[M].北京:科学出版社,2004,103-115.
[120]刘庆思.中西医结合诊治骨质疏松症[M].北京:中国中医药出版社,2001,73-91.
[121]李建华,编译.渐进抗阻训练对骨密度的影响回顾[J].国外医学.物理医学与康复分册,2000;20(4):171-173.
[122]Pluijm SM,Smit JH,Tromp EA,et al.A risk profile for identifying community-dwelling elderly with a high risk of recurrent falling:results of a 3-year prospective study.Osteoporos Int.2006,17(3):417-25.
[123]满君,侯明新,田野.增龄骨骼肌萎缩及运动对其影响机理的实验研究[J].中国运动医学杂志,2001;20,(3)248-249.
[124]曲绵域.运动医学[M].长春:长春出版社,2000,420-425.
[125]傅明,郑树森,廖威明.运动对切除卵巢大鼠骨代谢的影响[J].中国运动医学杂志,2000;19,(2)156-158.
[126]Wu J,Wang XX,Higuchi M,Yamada K,Ishimi Y.High bone mass gained by exercise in growing male mice is increased by subsequent reduced exercise.J Appl Physiol.2004,97(3):806-10.
[127]张林,杨锡让,薛延.运动与人体骨密度变化研究进展[J].北京体育大学 学报,2000;23(1):64-66.
[128]Schoutens A,Laurent E,Poortmans JR.Effects of inactivity and exercise on bone.Sports Med.1989,7(2):71-81.
[129]Izquierdo M,Ibanez J,Hakkinen K,et al.Maximal strength and power,muscle mass,endurance and serum hormones in weightlifters and road cyclists.J Sports Sci.2004,22(5):465-78.
[130]Micklesfield LK,Lambert EV,Fataar AB,et al.Bone mineral density in mature,premenopausal ultramarathon runners.Med Sci Sports Exerc.1995,27(5):688-96.
[131]Zanker CL,Cooke CB.Energy balance,bone turnover,and skeletal health in physically active individuals.Med Sci Sports Exerc.2004,36(8):1372-81.
[132]Nevill A,Holder R,Stewart A.Do sporting activities convey benefits to bone mass throughout the skeleton?.J Sports Sci.2004 Jul;22(7):645-50.
[133]杨玺.骨质疏松防治必读[M].上海:上海科学技术文献出版社,2003,126-127.
[134]林岳军,杨建伟,陈君,等.骨质疏松的运动疗法[J].国外医学.物理医学与康复学分册,2000;20(3):97-101.
[135]李建华,编译.渐进抗阻训练对骨密度的影响回顾[J].国外医学.物理医学与康复分册,2000;20(4):171-173.
[136]Schoutens A,Laurent E,Poortmans JR.Effects of inactivity and exercise on bone.Sports Med.1989,7(2):71-81.
[137]Wallace BA,Cumming RG.Systematic review of randomized trials of the effect of exercise on bone mass in pre-and postmenopausal women.Calcif Tissue Int.2000,67(1):10-8.
[138]Schoutens A,Laurent E,Poortmans JR.Effects of inactivity and exercise on bone.Sports Med.1989,7(2):71-81.
[139]章晓霜,高顺生,李青南.运动对实验性骨质疏松大鼠骨量的影响[J].中国康复医学杂志,2000;15(4):215-217.
[140]王人卫,高勇,陆爱云,等.大强度运动训练对雌性大鼠性激素和骨密度的影响[J].中国运动医学杂志,2003;22(2):121-124.
[141]杨维益,脾气需证大鼠骨骼肌的形态和形态计量研究[J],中国运动医学杂志,1993,12(3):157-159.;
[142]杨维益.健脾理气法对骨骼肌能量代谢影响的研究[J].中国运动医学杂志,1994,13(1):28.
[143]曹建民.补脾活血中药对小鼠运动时物质代谢机能的影响[J].北京体育大学学报,1995,18(1):28-32.
[144]杨树基.中药饮剂对恢复疲劳及提高运动成绩的作用[J].上海体育学院学报,1995,19(1):80.
[145]李兴泰 张家俊 陈文为.补气与理气中药及多糖类成分对鼠骨骼肌细胞能荷值的影响[J].北京中医药大学学报,2000,23(5):36-38.
[146]马建 刘波 罗小兵 戴国钢.大强度肌肉离心训练以及抗肌肉疲劳中药对家兔体重血红蛋白和脾脏组织结构影响的实验研究[J].中国运动医学杂志,2001,20(1):85-87.
[147]杨万同,廖维靖,刘玲俐等.当归对周围神经损伤后肌肉组织影响的实验研究[J].临床实用神经疾病杂志,1995,2(2):80-81.
[148]邵水金 单宝枝 余安胜 严振国.电针、中药对大鼠坐骨神经损伤后SFI 及肌肉影响的观察[J].中国针灸.1998,4:249-252.
[149]李开刚,吕丹云,高大安,杨维益.扶正、理气类中药“体复康”改善运动性疲劳的骨骼肌形态计量学研究[J].中国体视学与图像分析,1998,3(3):141-150.
[150]徐晓阳,张爱芳,武桂新等.扶正理气中药对大强度耐力训练大鼠糖代谢某 些指标的影响[J].中国运动医学杂志,1998,17(1):220-223.
[151]替俊平,吴怀春,尹昭云等。红景天中药复方改善机体骨骼肌能量代谢效果研究[J].解放军预防医学杂志.1999,13(3):183-186.
[152]陈孟华,李丽英,潘缉圣等.黄茂当归对肾病综合征大鼠肌肉蛋白质代谢的影响[J].中华肾脏病杂志,1997,13(3):153-155.]
[153]赵中应,冯连世,宗玉芳.理气扶正中药消除运动性疲劳过程中骨骼肌a-肌动蛋白基因的表达[J].中国运动医学杂志,1998,17(4):309-311.
[154]王斌,张蕴琨,蒋晓玲等.WL-I中药方剂对小鼠促力作用的观察[J],南京体育学院学报,1999,13(3):48-50.
[155]马东明,胡利民,马玉兰等.养肝柔筋方对大鼠运动中骨骼肌能量代谢的影响[J].天津中医学院学报,2002,21(3):46-48.
[156]吴颖昕,梅晓云,张喜芬等.振肌胶囊对大鼠疲劳模型骨骼肌细胞凋亡的影响[J].中医药学刊,2005,23(6):1005-1007.
[1]中国老年学会骨质疏松委员会骨质疏松诊断标准学科组.《中国人骨质疏松症建议诊断标准》(第二稿),中国骨质疏松杂志,2000;6(1):1-3.
[2]区品中,邓力平,沈怀亮,等.广州地区骨量峰值的调查研究.中国骨质疏松杂志,2002;8(1):78-81.
[3]沈自尹.中医虚证辨证参考标准.中西医结合杂志,1986;6(11):598.
[4]周文泉,王巍,霍玉书.延缓衰老中药的筛选规程和临床观察规范.中西医结合杂志,1986;6(11):684.
[5]周仲瑛,陈四清,周宁.健脾益肾、熄风通络法治疗重症肌无力[J].江苏 中医,2006,27(12):40-41.
[6]支惠萍,李庚和.痿病辨治首当“滋培水土”[J].上海中医药杂志,2005,39(8):39-40.
[7]刘少云.尚尔寿教授诊治重症肌无力经验摭拾[J].中医药学刊,2001(19):306.
[8]苏卫东,杨晓黎.从肝论治重症肌无力的几点看法[J].辽宁中 医杂志,2005,32(10):1022-1023.
[9]周慎.重症肌无力从肝论治[J].中医杂志,1995,36(9):568.
[10]刘炳凯,曹蓓蓓.曹鸣高治疗痿证的经验[J].四川中医,2000,18(12):1-2
[11]Albrand G,Munoz F,Sornay-Rendu E,et al.Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women:the OFELY study.Bone.2003 Jan;32(1):78-85.
[12]Nevitt MC.Epidemiology of osteoporosis.Rheum Dis Clin North Am.1994Aug;20(3):535-59.
[13]Gallagher JC.Role of estrogens in the management of post-menopausal bone loss.Rheum Dis Clin North Am,2001;27:143-162.
[14]O'connell D,Robertson,Henry D,et al.A systemic review of the sekeletal effects of estrogen therapy in postmenopausal women.An assessment of treatment effects Climacteric,1998;1:112-123.
[15]Taylor M.Alternatibes to conventional hormone placement therapy.Compr Ther,1997;23:514-532.
[16]杨欣,刘忠厚.骨强度在骨质疏松诊断中的作用[J].中国骨质疏松杂志,2003;9(3):279-282.
[17]Lanyon LE.Using functional loading to influence bone mass and architecture:objectives,mechanisms,and relationship with estrogen of the mechaically adaptive process in bone[J].Bone,1996;18:S37-S43.
[18]Frost RM.Perspectives on our age-ralated bone mass:insights from a new paradigm[J].J Bone Miner Res,1997;12:1539-1546.
[19]张林.运动对骨力学性能的影响——骨生物力学研究进展[J].中国运动医学杂志,2002;21(1):85-88.
[20]童普德,石印玉,吴小江,等.补肾益精方对卵巢切除大鼠股四头肌球蛋白重链基因mRNA表达的影响[J].中国中医骨伤科杂志,2001;9(4):1-4.
[21]Anna Mika,Viswanath B.Unnithan,Differences in Thoracic Kyphosis and in Back Muscle Strength in Women With Bone Loss due to Osteoporosis.SPINE.30(2):241-246.
[22]蒋春笋,张勇,时庆德.运动与衰老进程中线粒体氧应激介导的细胞凋亡[J].中国运动医学杂志,2001;20(2):185-189.
[23]Beckman KB,Ames BN.The free radical theory of aging mature[J].Physiol Rev.1999;78(2):547-581.
[24]任绮.不同方式的急性运动和慢性运动对自由基代谢的影响[J].体育科学,2004;24(4):22-25.
[25]张戈,石印玉,秦岭,等.绝经后髋部骨质疏松性骨折风险的研究进展[J].中国中医骨伤科杂志,2003;11(1):49-51.
[26]邓世琳,刘见华.雌激素的生物学作用及其对运动训练的意义[J].体育科学,2004;24(4):31-33.
[27]24.Chung S C.Effect of exercise during the follicular an luteal phase on indices of oxidative stress in healthy women[J].Med Sci Sports Exe,1999;31(3):409-413.
[28]魏扬,薛加强,林守清,等.绝经后应用激素替代治疗妇女的子宫内膜细胞形态观察[J].中华妇产科杂志,1997;32(3):432-435.
[29]陶欣,王冬颖,陈柏龄,等.雌激素不同给药方法对去卵巢大鼠子宫内膜安全性 的实验研究[J].中华老年医学杂志,2003;22(6):353-355.
[30]秦岭,张戈,译.美国国家卫生院有关骨质疏松症的预防、诊断和治疗的共识文件[J].中国骨质疏松杂志,2002;8(1):90-93.
[31]邵敏,黄宏兴,庄洪,等.骨康防治骨质疏松拆方的初步研究[J].中国中医骨伤科杂志,2000;8(2):7-8.
[32]刘庆思,陈仲泽,李小侬.骨康胶囊治疗绝经后骨质疏松症65例疗效观察[J].新中医,1995;27(10):31-32.
[33]邵敏,黄宏兴.中药含药血清对体外培养鼠破骨细胞的影响[J].中国中医骨伤科杂志,2003;11(1):22-24.
[34]邵敏,庄洪.含药血清对体外培养成骨细胞的影响[J].中国骨质疏松杂志,2003;9(2):117-119.
[35]冯新送,邵敏,黄洪兴.中药骨康对去势大鼠骨生物力学的影响[J].广州中医药大学学报,1998;15(3):211-212.
[36]熊学华,余克强,刘庆思.中药骨康对去势大鼠血清骨钙素及离体骨密度的影响[J].中国临床康复,2002;6(5):698-699.
[37]庄洪,邵敏.中药骨康对去势大鼠骨吸收与骨形成影响的实验研究[J].中国中医骨伤科杂志,2002;10(4):26-29.
[38]邵敏,黄宏兴,赵静.中药骨康治疗绝经后骨质疏松症疗效观察[J].中医正骨,2003;15(3):11-14.
[39]庄洪,魏合伟,林一峰.中药骨康含药血清中类雌二醇样物质含量的测定[J].中医正骨,2003;15(11):14-16.
[40]那晓琳,崔洪斌.大豆异黄酮的类雌激素作用与预防骨质疏松研究进展[J].中国骨质疏松杂志,2002;8(4):370-371.
[41]Setchell K.Phytoestrogens:The biochemistry,physiology,and implications for human health of soy is isoflavones[J].Am J Clin Nutr,1998;68(Suppl):1333s-1346s.
[42]满君,侯明新,田野.增龄骨骼肌萎缩及运动对其影响机理的实验研究[J].中国运动医学杂志,2001;20,(3)248-249.
[43]杨维益.健脾理气法对骨骼肌能量代谢影响的研究[J].中国运动医学杂志,1994;13(1):28-31.
[44]邱山东,郑安,林求诚.中老年性激素与抗氧化系统关系研究[J].中国老年学杂志,1999;19(2):70-73.
[45]刘思金,马学军,陈星飙,等.绝经后女体育教师与非运动老年女性骨密度和骨代谢生化标志物的研究[J].中国运动医学杂志,2001;20(2):151.
[46]刘洪珍,郭建军,武桂新.不同有氧耐力训练对肌组织自由基代谢和抗氧化系统的影响[J].中国运动医学杂志,2000;19(1):99-100.
[47]刘同想.运动对健康老人体征及自由基代谢的影响[J].中国运动医学杂志,1997;16(2):144-145.
[48]林燕萍,周瑞祥,马建华,等.健骨颗粒对骨质疏松模型大鼠垂体-肾上腺轴的影响[J].中国骨伤,2004;17(1):19-21.
[49]马振祥,周鸣鸣,刘梅.中药神经生长液对自然衰老小鼠脑SOD活性和MDA 含量的影响[J].中国老年学杂志,2004;24(3):770.
[50]金勋杰,吴铁,李青南,等.补骨胶囊与17α-炔雌醇联合用药对大鼠骨质疏松的预防及对子宫刺激作用的研究[J].中国骨伤,2003;16(5):272-274.
[51]陆泽元,廖二元,伍贤平,等.去卵巢对大鼠骨密度的影响[J].中国骨质疏松杂志,2002;8(1):13-15.
[52]陶欣,王冬颖,陈柏龄,等.雌激素不同给药方法对去卵巢大鼠子宫内膜安全性的实验研究[J].中华老年医学杂志,2003;22(6):353-355.
[53]徐栋梁,何爱珊,李佛保,等.锻炼配合抗骨吸收剂治疗绝经后骨质疏松症的临床研究[J].中国骨质疏松杂志,2002;8(2):153-155.
[54]夏秦,汪红兵,刘晓晴.运动与活性维生素D联合治疗作用对老年骨质疏松患者骨量的影响[J].中华物理医学与康复杂志,2004;26(5):291-293.
[2]丁桂芝,张忠兰,周勇等。补肾健骨胶囊治疗绝经后骨质疏松症疗效分析。中国中西医结合杂志,1995,15(7):392。
[3]谢雁鸣,张方直,周文泉等。补肾生髓胶囊治疗肾阳虚证原发性骨质疏松症的临床研究,中国中西医结合杂志,1997,17(9):526。
[4]史炜镔,王济伟,符诗聪等。骨松Ⅰ号治疗绝经后骨质疏松症初步临床观察,中国骨伤,1996,9(6):3
[5]王和鸣,葛继荣,李楠。补骨合剂治疗老年性骨质疏松的临床观察,中国中医骨伤科杂志,1998,6(4):13
[6]李洪成,郭素华,林如平等。补肾药虎潜丸对肾虚患者骨密度的影响,中国中西医结合杂志,1997,17(11):669。
[7]周丕琪,沈霖,杨艳萍等。密骨片治疗绝经后骨质疏松症的临床研究,中国中医骨伤杂志1995,5(1):20-22
[8]蒋淑媛,尚亚平,吴林生等。骨疏康颗粒治疗骨质疏松症的临床观察(附300例分析),中国骨质疏松杂志,1995,1(2):167。,1997,5(1):20。
[9]赵永芳,张戈,史万忠等。骨质疏松症中医证型的初步临床报告,中医正骨,141998,10(5):9。
[10]邵敏,庄洪,宋文昭。绝经后骨质疏松症生存质量和中医证型的初步研究,中医正骨,2000,12(5):9。
[11]谢可永.补肾法治疗骨质疏松症55例疗效观察,上海中医药杂志,1986,27 (11)
[12]梁立.补肾中药治疗骨质疏松症的临床观察。中医杂志,1992,33(11):39。
[13]张贵有。老年性骨质疏松症中医证治探讨,浙江中医学院学报,1996,20(1):8。
[14]齐振熙。辩证治疗绝经后骨质疏松症,中国中医骨伤科杂志,1998,6(3):28。
[15]黄勇。老年性脊椎骨质疏松并压缩骨折的诊治-附53例报告,中医正骨,1993,4(3):13。
[16]许书亮,张永重。骨质疏松症的辩证分型与治疗,中国中医骨伤科杂志,3(4):30。
[17]丛春雨。女性绝经后骨质疏松症的中医中药治疗,中国骨质疏松杂志,1999,5(4):7。
[18]史炜镔,杜宁,符诗聪等。中药对去势兔骨代谢影响的骨计量学研究,中国中医骨伤科杂志,1996,4(4):8。
[19]丁桂芝,周勇,李榕等。补肾健骨胶囊防治维甲酸造成的大鼠骨质疏松症的研究,同济医科大学学报,1995,24(4):285。
[20]吴波,徐冰,黄添友等。抗骨松剂对维甲酸所致骨质疏松症的防治作用,中国中西医结合杂志,1996,16(1):32。
[21]刘和娣,李恩,佟晓旭等。补肾方药对地塞米松诱发的骨质疏松大鼠体内雌激素和1,25羟维生素D3的影响,中国中西医结合杂志,1993,13(9):544。
[22]谢晶,杜靖远,沈霖。补肾密骨液作用于卵巢切除大鼠的骨组织计量学研究,中国中医骨伤科杂志,1995,3(6):1。
[23]冯坤,刘月桂,张灵菊等。中药坚骨液对卵巢切除后骨质疏松大鼠血、尿生化的影响,中医正骨,1996,8(1):3。
[24]陶有略,方亮,叶大付等。黔岭藿合剂对大鼠卵巢切除诱发实验性骨质疏 松症的影响,中国中医骨伤科杂志,4(6):10。
[25]沈霖,杜靖远,杨家玉等。密骨片防治去睾大鼠骨质疏松症的研究,中国中医骨伤科杂志,1997,5(1):4。
[26]姚共和,谢林,郭振球。金刚健骨片对绝经后骨质疏松症骨形成与骨吸收失衡的双向调节作用,中国中医骨伤科杂志,1999,7(2):6。
[27]杜靖远,沈霖,杨家玉等。补肾密骨液对大鼠卵巢切除诱导的实验性骨质疏松症的影响,中华骨科杂志,1996,16(7):462。
[28]李青南,疗进民,吴铁等。淫羊藿预防羟基尿致雄性大鼠骨质疏松的定量研究,中国中医骨伤科杂志,1996,4(3):1。
[29]孙苏亚,王锦,刘铮等。龟板提取液对去势大鼠骨质疏松的作用,中药药理与临床,1998,4(4):20。
[30]季晖,刘康,李绍平等。淫羊藿总黄酮对维A酸诱导大鼠骨质疏松症的防治作用,中国药科大学学报,2000,3(3):222。
[31]马中书,王蕊,邱明才等。四种补肾中药对去卵巢大鼠骨质疏松骨形态的作用,中华妇产科杂志,1999,34(2):82。
[32]于世风,陈坤,章魁华等。中药对骨吸收作用的实验研究,现代口腔医学杂志,1999,13(1):1。
[33]李朝阳,吴铁,黄连芳等。黄芪水提液与已烯雌酚对去卵巢大鼠骨代谢的影响,中草药,1998,29(1):27。
[34]沈霖,杜靖远,赵海波。补肾法对IL-1诱导的破骨细胞性骨吸收及破骨细胞MMP-9的影响,中医正骨,1999,11(7):3。
[35]沈霖,杜靖远,赵海波。补肾法对实验性骨质疏松MMP-9及Ⅰ型胶原mRNA 表达的影响,中国中医骨伤科杂志,1998,6(4):1。
[36]唐海涛,唐海,罗先正等。骨疏康对成骨细胞刺激作用的研究,中国骨质疏松杂志,2000,6(2):60。
[37]沈霖,杜靖远,胡光亮等。密骨片对离体胎鼠颅骨成骨细胞增殖及及幼鼠 颅骨块钙释放的影响,中医研究,2000,13(1):22。
[38]李芳芳,李恩,宋士军等。补肾方剂及不同分离组份对成骨细胞增殖分化的影响,中国骨质疏松杂志,1998,4(3):71。
[39]杜靖远,胡光亮。夏志道等。补肾密骨液对体外培养新生大鼠颅骨成骨细胞增殖的影响,中华实验外科杂志,1998,15(5):465。
[40]郭昭庆,党耕町,王志国。氟化钠及续断组份对成骨细胞增殖的影响,中华骨科杂志,1998,18(2):84。
[41]黄岚,冯树芳,王洪复等。雷公藤内酯醇对体外培养的成骨细胞增殖的影响,中华皮肤科杂志,2000,33(2):96。
[42]黄岚,冯树芳,魏道材等。雷公藤多甙体外对成骨细胞功能表达的影响,中华风湿病学杂志,2000,4(2):
[43]黄岚,冯树芳,王洪复等。雷公藤多甙对体外成骨细胞增殖的影响,上海医科大学学报,2000,27(1):51。
[44]李学武,李晓泓,张露芬等。天灸防治去卵巢大鼠骨质疏松的实验研究,中国骨质疏松杂志,1998,4(3):58。
[45]刘献祥,吴炳煌,吴明霞等。针灸对原发性骨质疏松症影响的实验研究,福建中医学院学报,2000,10(1):21。
[46]赵英侠,严振国,余安胜。针灸对卵巢切除大鼠骨代谢的影响,上海针灸杂志,1999,18(5):40。
[47]孙晓明,罗南萍,杨道理等。珍牡胶囊与霜叶红联用对老年男性骨质疏松患者骨代谢指标的影响,放射免疫学杂志,2000,13(2):75。
[48]崔少千,王海义,李书琴等。骨疏康冲剂与钙剂联合应用防治维甲酸所致大鼠骨质疏松的实验研究,中国骨质疏松杂志,1999,5(2):74。
[49]尹文哲,王伟,敖英芳。阿法D3与补肾健骨胶囊联合使用对大鼠实验性骨质疏松的影响,中国运动医学杂志,1999,18(1):282。
[50]张乃钲,韩旭华。中西医结合治疗绝经后骨质疏松症的研究,中国中医骨 伤科杂志,1995,3(1):14。
[51]Xiaobo Wanga,Genevi'eve A.Dumasa.Evaluation of effects of selected factors on intervertebral fusion a simulation study.Medical Engineering &Physics,2005,27:197-207.
[52]White Ⅲ AA,Panjabi MM.Clinical Biomechanics of the Spine.Philadelphia:J.B.Lippincott,1990.
[53]Hukins DWL.Disc structure and function.In:Ghosh P,ed.The Biology of the Intervertebral Disk I.Boca Raton,Florida;CRC Press,1988:1-37.
[54]Smit TH,Odgaard A,Schneider E.Structure and function of vertebral trabecular bone.Spine.1997 Dec 15;22(24):2823-33.
[55]李健,徐晖,程立明等.胸腰段椎体压缩性骨折三维有限元模型的建立及其意义.中国临床解剖学杂志.2005,23(2):199-201.
[56]Xiaobo Wanga,Genevi'eve A.Dumasa.Evaluation of effects of selected factors on intervertebral fusion a simulation study.Medical Engineering &Physics,2005,27:197-207.
[57]赵燕玲,潘子昂,王石麟。中国原发性骨质疏松症流行病学,中国骨质疏松杂志,1998,4(1):1.
[58]张平,李健,张美超,等.胸腰段三维有限元模型的建立.2005,33(4):7-10.
[59]程立明,陈仲强,张美超等.胸腰段后凸畸形对相邻椎间盘力学影响的三维有限元分析.中国临床解剖学杂志,2003,21(3):273-276.
[60]吴浩波,严世贵,陈其昕等.不同运动负荷下腰椎应力的三维非线性有限元分析.中国运动医学杂志,2004,23(5):480-484.
[61]陈新民,郎继孝,陈德喜等.应用三维有限元模型研究颈的生物力学变化.临床骨科杂志.2003,6(4):294-296.
[62]中国老年学会骨质疏松委员会骨质疏松诊断标准学科组.中国人骨质疏松症建议诊断标准(第二版)[J].中国骨质疏松杂志,2000;6(1):1-3
[63]包丽华,林华,李建华,等.二瞵酸盐治疗对骨质疏松性骨痛、骨密度、骨强度的疗效及安全性评价[J].中华老年医学杂志,2003;22(11):659-662.
[64]秦岭,张戈,译.美国国家卫生院有关骨质疏松症的预防、诊断和治疗的共识文件[J].中国骨质疏松杂志,2002;8(1):90-93.
[65]郝永强,戴克戎.骨质疏松性骨折愈合的细胞超微结构观察.中华骨科杂志,2004,24(11):670-673.
[66]Melton Ⅲ LJ,Chrischilles EA,etal.Perspective How many women have osteoporosis.J Bone Miner Res.1992;7:1005-10.
[67]EPOS-group.Incidence of vertebral fracture in Europe:results from the European Prospective Osteoporosis Study(EPOS).J Bone Miner Res 2002;17:716-24.
[68]J.A.Kanis,O.Johnell A.Oden F.Borgstrom N.Zethraeus C.De Laet B.JonssonThe risk and burden of vertebral fractures in Sweden.Osteoporos Int (2004)15:20-26.
[69]Mosekilde L.Consequences of the remodelling process for vertebral trabecular bone structure:a scanning electron microscopy study(uncoupling of unloaded structures).Bone Miner 1990;10:13-35.
[70]J.Homminga,B.Van-Rietbergen,E.M.Lochmu,et al.The osteoporotic vertebral structure is well adapted to the loads of dally life,but not to infrequent‘error'loads.Bone,2004,34:510-516.
[71]Fechtenbaum J,Cropet C,Kolta S,et al.The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women.Osteoporos Int.2005,16(12):2175-9.
[72]Cummings SR,Kelsey JL,Nevitt MC,et al..Epidemiology of osteoporosis and osteoporotic fracture[J].Epide mid Rev,1985,7:178-208.
[73]Speocer H,Kraner L.NIH consensus conference:Osteoporosis,factors contributing to osteoporosis[J].J Nutr,1986,116:319-322.
[74]Peck WA.The nature and epidemiology of osteoporosis.In:Peck WA,eds.Trends and Perspectives in the Diagnosis and Management of Osteoporosis.New Jersey:The Parthenon Publishing Group,1989;11-19.
[75]Gueguen Y,Bard M.The understanding and recognition of osteoporosis.Switzerland,1989;34.
[76]J.A.Kanis,O.Johnell A.etal.The risk and burden of vertebral fractures in Sweden.Osteoporos Int,2004,15:20-26.
[77]郭庆升,孙国强,张世斌,等.应用双能X线骨密度仪对辽宁地区正常人群骨密度的流行病学调查[J]中国骨质疏松杂志,2002,8(2),107-9.
[78]安珍,王文志,杨定焯,等.成都地区城乡人群原发性骨质疏松调查[J].中国骨质疏松杂志,2002,8(3):233-6.
[79]林伟,邓力平,邬恒夫,等.广州地区1530例骨密度分析及骨质疏松发病率研究[J]中国骨质疏松杂志,2003,9(3),257-9.
[80]徐栋梁,李佛保,陈维清,等,广州地区老年人群骨质疏松性骨折和骨关节病的流行病学调查和分析[J]中国骨质疏松杂志,2000,6(3),73-6.
[81]区品中,邓力平,刘毅生,等.广州地区中老年人群骨量减少及骨质疏松患病率的调查[J]中国骨质疏松杂志,2003,8(4)314-8.
[82]陈健,陈治卿,余玲玲,等.厦门岛中老年人骨质疏松症发病率调查[J].四川医学,2001,22(8),785-787.
[83]Mosekide L,Bentzen SM,The predictive value of quantitative computed tomography for vertebral body compressive strength and ash desity.Bone,1989,10:465.
[84]Goldstein SA,Goulet R.McCubbrey D,Measurement and significance of three-dimensional architecture in mechanical integrity of trabecular bone.Calcif Tissue Int,1993,53:S127.
[85]Johnell O,Kanis JA,etal.Predictive value of BMD for hip and other fractures.J Bone Miner Res.2005,20(7):1185-94.
[86]Sornay-Rendu E,Munoz F,Garnero P,et al.Identification of osteopenic women at high risk of fracture:the OFELY study.J Bone Miner Res.2005,20(10):1813-9.
[87]Chevalley T,Hoffmeyer P,Bonjour JP,Rizzoli R.An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture.Osteoporos Int;2002,13:450-455.
[88]Mulherin D,Williams S,Smith JA,et al.Identification of risk factors for future fracture in patients following distal forearm fracture.Osteoporos Int.2003Sep;14(9):757-60.
[89]郭世绂 骨质疏松性椎体骨折 中国矫形外科杂志2005年11月第13卷第22期1685-1687.
[90]Cuddihy MT,Gabriel SE,Crowson CS,O'Fallon WM,Melton LJ.Forearm fractures as predictors of subsequent osteoporotic fractures.Osteoporos Int.1999,9:469-475.
[91]Cummings SR.Case-finding for prevention of fractures.Osteoporosis ensitometry,diagnosis,treatment,prevention,rehabilitation and patient education,2000:73-75.
[92]Seeman E.Clinial approach to patients with osteoporosis.Osteoporosis ensitometry,diagnosis,treatment,prevention,rehabilitation and patient education,2000:17-25.
[93]Kanis JA,Johnell O,etal.A meta-analysis of previous fracture and subsequent fracture risk.Bone.2004,35(2):375-82.
[94]Barthe N,Basse-Cathalinat B,Meunier PJ,et al.Measurement of bone mineral density in monther-daughter pairs for evaluating the family influence on bone mass acquisition:a GRIO survey.Osteoporos Int,1998,8:379-384.
[95]De Laet C,Kanis JA,et al.Body mass index as a predictor of fracture risk:a meta-analysis.Osteoporos Int.2005,16(11):1330-8.
[96]Sornay-Rendu E,Munoz F,et al.Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women:the OFELY study.J Bone Miner Res.2005,20(11):1929-35.
[97]Mikko Haara,Markku Heli(o|¨)vaara3,Olli Impivaara3,et al.Low metacarpal index predicts hip fracture:A prospective population study of 3,561 subjects with 15 years of follow-up.Acta Orthopaedica 2006,77(1):9-14.
[98]Sornay-Rendu E,Munoz F,etal.Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women:the OFELY Study.J Bone Miner Res.2004,19(12):1994-1999.
[99]Ross PD,Davis JW,Epstein RS,Wasnich RD.Pre-existing fractures and bone mass predict vertebral fracture incidence in women.Ann Intern Med.1991,114(11):919-23.
[100]Black DM,Arden NK,Palermo L,et al.Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures.Study of Osteoporotic Fractures Research Group.J Bone Miner Res.1999,14(5):821-8.
[101]Garnero P,Delmas PD.Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.J Musculoskelet Neuronal Interact.2004,4(1):50-63.
[102]张彤,李万根.绝经后妇女血清瘦素水平与骨代谢的关系.中国骨质疏松杂志,2005,11(3):317-318.
[103]Kanis JA,Johansson H,etal.Alcohol intake as a risk factor for fracture.Osteoporos Int.2005,16(7):737-42.
[104]Albrand G,Munoz F,et al.Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women:the OFELY study.Bone.2003,32(1):78-85.;Kanis JA,Borgstrom F,etal.Assessment of fracture risk.Osteoporos Int.2005,16(6):581-9.
[105]Maldague BE,Noel HM,Malgheim JJ.The intra vertebral vacuum cleft:a sign of ischemic vertebral collapse.Radiology 1978;129:23-9.
[106]Hashimoto K,Yasui N,Yamagishi M,Kojimoto H,Mizuno K,Shimomura Y.Intra vertebral vacuum cleft in the fifth vertebra.Spinel989;14:351-4.
[107]Baba H,Maezawa Y,Kamitani K,et al.Osteoporotic vertebral collapse with late neurological complications.Paraplegia 1995;33:281-9.;Brower AC,Downey EF.Kummell disease:report of a case with serial radiographs.Radiology 1981;141:363-4.
[108]Cho LM,Knight RQ.Idiopathic avascular necrosis of a vertebral body.Case report and literature review.Spine 1997;22:1928-32.
[109]Hasegawa K,Homma T,Uchiyama S,Takahashi H.Vertebral pseudarthrosis in the osteoporotic spine.Spine 1998;23:2201-6.
[110]Kaplan PA,Orton DF,Aselson RJ.Osteoporosis with vertebral compression fractures,retropulsed fragments,and neurologic compromise.Radiology 1987;165:533-5.
[111]刘忠厚.骨质疏松学[M].科学出版社,1998:142.
[112]沈光宇,杨卫新.康复医学[M].南京:东南大学出版社,2002:104-105.
[113]谭文捷,周宏图.脉冲电磁场并紫外线照射治疗骨质疏松症234例.中国临床康复.2003,15:2223.
[114]谭文捷,周宏图.绝经后骨质疏松症综合康复治疗86例.江苏大学学报(医 学版).2003,13(4):342-343.
[115]翁瑛霞 高巧英 邵宏伟等.126例骨质疏松患者的疼痛与脉冲电磁场疗效的初步分析.中国骨质疏松杂志,2003,9(4):317-319.
[116]高家纯,高巧英.脉冲电磁场改善骨质疏松症患者关节疼痛及痉挛症状849例观察.中国临床康复.2004,8(6):1720-1721.
[117]罗文娟,张小红,陈敏.中药离子导入治疗骨质疏松症疼痛效果观察及护理.护理学杂志,2004,19(8):65-66.
[118]黎小坚,Harold M Frost,朱绍舜,等.基础骨生物学新观[J].中国骨质疏松杂志,2001;7(3):253-261.
[119]肖建德.实用骨质疏松学[M].北京:科学出版社,2004,103-115.
[120]刘庆思.中西医结合诊治骨质疏松症[M].北京:中国中医药出版社,2001,73-91.
[121]李建华,编译.渐进抗阻训练对骨密度的影响回顾[J].国外医学.物理医学与康复分册,2000;20(4):171-173.
[122]Pluijm SM,Smit JH,Tromp EA,et al.A risk profile for identifying community-dwelling elderly with a high risk of recurrent falling:results of a 3-year prospective study.Osteoporos Int.2006,17(3):417-25.
[123]满君,侯明新,田野.增龄骨骼肌萎缩及运动对其影响机理的实验研究[J].中国运动医学杂志,2001;20,(3)248-249.
[124]曲绵域.运动医学[M].长春:长春出版社,2000,420-425.
[125]傅明,郑树森,廖威明.运动对切除卵巢大鼠骨代谢的影响[J].中国运动医学杂志,2000;19,(2)156-158.
[126]Wu J,Wang XX,Higuchi M,Yamada K,Ishimi Y.High bone mass gained by exercise in growing male mice is increased by subsequent reduced exercise.J Appl Physiol.2004,97(3):806-10.
[127]张林,杨锡让,薛延.运动与人体骨密度变化研究进展[J].北京体育大学 学报,2000;23(1):64-66.
[128]Schoutens A,Laurent E,Poortmans JR.Effects of inactivity and exercise on bone.Sports Med.1989,7(2):71-81.
[129]Izquierdo M,Ibanez J,Hakkinen K,et al.Maximal strength and power,muscle mass,endurance and serum hormones in weightlifters and road cyclists.J Sports Sci.2004,22(5):465-78.
[130]Micklesfield LK,Lambert EV,Fataar AB,et al.Bone mineral density in mature,premenopausal ultramarathon runners.Med Sci Sports Exerc.1995,27(5):688-96.
[131]Zanker CL,Cooke CB.Energy balance,bone turnover,and skeletal health in physically active individuals.Med Sci Sports Exerc.2004,36(8):1372-81.
[132]Nevill A,Holder R,Stewart A.Do sporting activities convey benefits to bone mass throughout the skeleton?.J Sports Sci.2004 Jul;22(7):645-50.
[133]杨玺.骨质疏松防治必读[M].上海:上海科学技术文献出版社,2003,126-127.
[134]林岳军,杨建伟,陈君,等.骨质疏松的运动疗法[J].国外医学.物理医学与康复学分册,2000;20(3):97-101.
[135]李建华,编译.渐进抗阻训练对骨密度的影响回顾[J].国外医学.物理医学与康复分册,2000;20(4):171-173.
[136]Schoutens A,Laurent E,Poortmans JR.Effects of inactivity and exercise on bone.Sports Med.1989,7(2):71-81.
[137]Wallace BA,Cumming RG.Systematic review of randomized trials of the effect of exercise on bone mass in pre-and postmenopausal women.Calcif Tissue Int.2000,67(1):10-8.
[138]Schoutens A,Laurent E,Poortmans JR.Effects of inactivity and exercise on bone.Sports Med.1989,7(2):71-81.
[139]章晓霜,高顺生,李青南.运动对实验性骨质疏松大鼠骨量的影响[J].中国康复医学杂志,2000;15(4):215-217.
[140]王人卫,高勇,陆爱云,等.大强度运动训练对雌性大鼠性激素和骨密度的影响[J].中国运动医学杂志,2003;22(2):121-124.
[141]杨维益,脾气需证大鼠骨骼肌的形态和形态计量研究[J],中国运动医学杂志,1993,12(3):157-159.;
[142]杨维益.健脾理气法对骨骼肌能量代谢影响的研究[J].中国运动医学杂志,1994,13(1):28.
[143]曹建民.补脾活血中药对小鼠运动时物质代谢机能的影响[J].北京体育大学学报,1995,18(1):28-32.
[144]杨树基.中药饮剂对恢复疲劳及提高运动成绩的作用[J].上海体育学院学报,1995,19(1):80.
[145]李兴泰 张家俊 陈文为.补气与理气中药及多糖类成分对鼠骨骼肌细胞能荷值的影响[J].北京中医药大学学报,2000,23(5):36-38.
[146]马建 刘波 罗小兵 戴国钢.大强度肌肉离心训练以及抗肌肉疲劳中药对家兔体重血红蛋白和脾脏组织结构影响的实验研究[J].中国运动医学杂志,2001,20(1):85-87.
[147]杨万同,廖维靖,刘玲俐等.当归对周围神经损伤后肌肉组织影响的实验研究[J].临床实用神经疾病杂志,1995,2(2):80-81.
[148]邵水金 单宝枝 余安胜 严振国.电针、中药对大鼠坐骨神经损伤后SFI 及肌肉影响的观察[J].中国针灸.1998,4:249-252.
[149]李开刚,吕丹云,高大安,杨维益.扶正、理气类中药“体复康”改善运动性疲劳的骨骼肌形态计量学研究[J].中国体视学与图像分析,1998,3(3):141-150.
[150]徐晓阳,张爱芳,武桂新等.扶正理气中药对大强度耐力训练大鼠糖代谢某 些指标的影响[J].中国运动医学杂志,1998,17(1):220-223.
[151]替俊平,吴怀春,尹昭云等。红景天中药复方改善机体骨骼肌能量代谢效果研究[J].解放军预防医学杂志.1999,13(3):183-186.
[152]陈孟华,李丽英,潘缉圣等.黄茂当归对肾病综合征大鼠肌肉蛋白质代谢的影响[J].中华肾脏病杂志,1997,13(3):153-155.]
[153]赵中应,冯连世,宗玉芳.理气扶正中药消除运动性疲劳过程中骨骼肌a-肌动蛋白基因的表达[J].中国运动医学杂志,1998,17(4):309-311.
[154]王斌,张蕴琨,蒋晓玲等.WL-I中药方剂对小鼠促力作用的观察[J],南京体育学院学报,1999,13(3):48-50.
[155]马东明,胡利民,马玉兰等.养肝柔筋方对大鼠运动中骨骼肌能量代谢的影响[J].天津中医学院学报,2002,21(3):46-48.
[156]吴颖昕,梅晓云,张喜芬等.振肌胶囊对大鼠疲劳模型骨骼肌细胞凋亡的影响[J].中医药学刊,2005,23(6):1005-1007.
[1]中国老年学会骨质疏松委员会骨质疏松诊断标准学科组.《中国人骨质疏松症建议诊断标准》(第二稿),中国骨质疏松杂志,2000;6(1):1-3.
[2]区品中,邓力平,沈怀亮,等.广州地区骨量峰值的调查研究.中国骨质疏松杂志,2002;8(1):78-81.
[3]沈自尹.中医虚证辨证参考标准.中西医结合杂志,1986;6(11):598.
[4]周文泉,王巍,霍玉书.延缓衰老中药的筛选规程和临床观察规范.中西医结合杂志,1986;6(11):684.
[5]周仲瑛,陈四清,周宁.健脾益肾、熄风通络法治疗重症肌无力[J].江苏 中医,2006,27(12):40-41.
[6]支惠萍,李庚和.痿病辨治首当“滋培水土”[J].上海中医药杂志,2005,39(8):39-40.
[7]刘少云.尚尔寿教授诊治重症肌无力经验摭拾[J].中医药学刊,2001(19):306.
[8]苏卫东,杨晓黎.从肝论治重症肌无力的几点看法[J].辽宁中 医杂志,2005,32(10):1022-1023.
[9]周慎.重症肌无力从肝论治[J].中医杂志,1995,36(9):568.
[10]刘炳凯,曹蓓蓓.曹鸣高治疗痿证的经验[J].四川中医,2000,18(12):1-2
[11]Albrand G,Munoz F,Sornay-Rendu E,et al.Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women:the OFELY study.Bone.2003 Jan;32(1):78-85.
[12]Nevitt MC.Epidemiology of osteoporosis.Rheum Dis Clin North Am.1994Aug;20(3):535-59.
[13]Gallagher JC.Role of estrogens in the management of post-menopausal bone loss.Rheum Dis Clin North Am,2001;27:143-162.
[14]O'connell D,Robertson,Henry D,et al.A systemic review of the sekeletal effects of estrogen therapy in postmenopausal women.An assessment of treatment effects Climacteric,1998;1:112-123.
[15]Taylor M.Alternatibes to conventional hormone placement therapy.Compr Ther,1997;23:514-532.
[16]杨欣,刘忠厚.骨强度在骨质疏松诊断中的作用[J].中国骨质疏松杂志,2003;9(3):279-282.
[17]Lanyon LE.Using functional loading to influence bone mass and architecture:objectives,mechanisms,and relationship with estrogen of the mechaically adaptive process in bone[J].Bone,1996;18:S37-S43.
[18]Frost RM.Perspectives on our age-ralated bone mass:insights from a new paradigm[J].J Bone Miner Res,1997;12:1539-1546.
[19]张林.运动对骨力学性能的影响——骨生物力学研究进展[J].中国运动医学杂志,2002;21(1):85-88.
[20]童普德,石印玉,吴小江,等.补肾益精方对卵巢切除大鼠股四头肌球蛋白重链基因mRNA表达的影响[J].中国中医骨伤科杂志,2001;9(4):1-4.
[21]Anna Mika,Viswanath B.Unnithan,Differences in Thoracic Kyphosis and in Back Muscle Strength in Women With Bone Loss due to Osteoporosis.SPINE.30(2):241-246.
[22]蒋春笋,张勇,时庆德.运动与衰老进程中线粒体氧应激介导的细胞凋亡[J].中国运动医学杂志,2001;20(2):185-189.
[23]Beckman KB,Ames BN.The free radical theory of aging mature[J].Physiol Rev.1999;78(2):547-581.
[24]任绮.不同方式的急性运动和慢性运动对自由基代谢的影响[J].体育科学,2004;24(4):22-25.
[25]张戈,石印玉,秦岭,等.绝经后髋部骨质疏松性骨折风险的研究进展[J].中国中医骨伤科杂志,2003;11(1):49-51.
[26]邓世琳,刘见华.雌激素的生物学作用及其对运动训练的意义[J].体育科学,2004;24(4):31-33.
[27]24.Chung S C.Effect of exercise during the follicular an luteal phase on indices of oxidative stress in healthy women[J].Med Sci Sports Exe,1999;31(3):409-413.
[28]魏扬,薛加强,林守清,等.绝经后应用激素替代治疗妇女的子宫内膜细胞形态观察[J].中华妇产科杂志,1997;32(3):432-435.
[29]陶欣,王冬颖,陈柏龄,等.雌激素不同给药方法对去卵巢大鼠子宫内膜安全性 的实验研究[J].中华老年医学杂志,2003;22(6):353-355.
[30]秦岭,张戈,译.美国国家卫生院有关骨质疏松症的预防、诊断和治疗的共识文件[J].中国骨质疏松杂志,2002;8(1):90-93.
[31]邵敏,黄宏兴,庄洪,等.骨康防治骨质疏松拆方的初步研究[J].中国中医骨伤科杂志,2000;8(2):7-8.
[32]刘庆思,陈仲泽,李小侬.骨康胶囊治疗绝经后骨质疏松症65例疗效观察[J].新中医,1995;27(10):31-32.
[33]邵敏,黄宏兴.中药含药血清对体外培养鼠破骨细胞的影响[J].中国中医骨伤科杂志,2003;11(1):22-24.
[34]邵敏,庄洪.含药血清对体外培养成骨细胞的影响[J].中国骨质疏松杂志,2003;9(2):117-119.
[35]冯新送,邵敏,黄洪兴.中药骨康对去势大鼠骨生物力学的影响[J].广州中医药大学学报,1998;15(3):211-212.
[36]熊学华,余克强,刘庆思.中药骨康对去势大鼠血清骨钙素及离体骨密度的影响[J].中国临床康复,2002;6(5):698-699.
[37]庄洪,邵敏.中药骨康对去势大鼠骨吸收与骨形成影响的实验研究[J].中国中医骨伤科杂志,2002;10(4):26-29.
[38]邵敏,黄宏兴,赵静.中药骨康治疗绝经后骨质疏松症疗效观察[J].中医正骨,2003;15(3):11-14.
[39]庄洪,魏合伟,林一峰.中药骨康含药血清中类雌二醇样物质含量的测定[J].中医正骨,2003;15(11):14-16.
[40]那晓琳,崔洪斌.大豆异黄酮的类雌激素作用与预防骨质疏松研究进展[J].中国骨质疏松杂志,2002;8(4):370-371.
[41]Setchell K.Phytoestrogens:The biochemistry,physiology,and implications for human health of soy is isoflavones[J].Am J Clin Nutr,1998;68(Suppl):1333s-1346s.
[42]满君,侯明新,田野.增龄骨骼肌萎缩及运动对其影响机理的实验研究[J].中国运动医学杂志,2001;20,(3)248-249.
[43]杨维益.健脾理气法对骨骼肌能量代谢影响的研究[J].中国运动医学杂志,1994;13(1):28-31.
[44]邱山东,郑安,林求诚.中老年性激素与抗氧化系统关系研究[J].中国老年学杂志,1999;19(2):70-73.
[45]刘思金,马学军,陈星飙,等.绝经后女体育教师与非运动老年女性骨密度和骨代谢生化标志物的研究[J].中国运动医学杂志,2001;20(2):151.
[46]刘洪珍,郭建军,武桂新.不同有氧耐力训练对肌组织自由基代谢和抗氧化系统的影响[J].中国运动医学杂志,2000;19(1):99-100.
[47]刘同想.运动对健康老人体征及自由基代谢的影响[J].中国运动医学杂志,1997;16(2):144-145.
[48]林燕萍,周瑞祥,马建华,等.健骨颗粒对骨质疏松模型大鼠垂体-肾上腺轴的影响[J].中国骨伤,2004;17(1):19-21.
[49]马振祥,周鸣鸣,刘梅.中药神经生长液对自然衰老小鼠脑SOD活性和MDA 含量的影响[J].中国老年学杂志,2004;24(3):770.
[50]金勋杰,吴铁,李青南,等.补骨胶囊与17α-炔雌醇联合用药对大鼠骨质疏松的预防及对子宫刺激作用的研究[J].中国骨伤,2003;16(5):272-274.
[51]陆泽元,廖二元,伍贤平,等.去卵巢对大鼠骨密度的影响[J].中国骨质疏松杂志,2002;8(1):13-15.
[52]陶欣,王冬颖,陈柏龄,等.雌激素不同给药方法对去卵巢大鼠子宫内膜安全性的实验研究[J].中华老年医学杂志,2003;22(6):353-355.
[53]徐栋梁,何爱珊,李佛保,等.锻炼配合抗骨吸收剂治疗绝经后骨质疏松症的临床研究[J].中国骨质疏松杂志,2002;8(2):153-155.
[54]夏秦,汪红兵,刘晓晴.运动与活性维生素D联合治疗作用对老年骨质疏松患者骨量的影响[J].中华物理医学与康复杂志,2004;26(5):291-293.